These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9333138)

  • 1. The hyperprostaglandin E syndrome: a hypercalciuric variant of Bartter's syndrome.
    Welch TR
    J Bone Miner Res; 1997 Oct; 12(10):1753-4. PubMed ID: 9333138
    [No Abstract]   [Full Text] [Related]  

  • 2. Normal prostaglandinuria E2 in Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome.
    Lüthy C; Bettinelli A; Iselin S; Metta MG; Basilico E; Oetliker OH; Bianchetti MG
    Am J Kidney Dis; 1995 Jun; 25(6):824-8. PubMed ID: 7771477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant of Bartter's syndrome. Bartter's syndrome associated with hydramnios, prematurity, hypercalciuria and nephrocalcinosis.
    Ohlsson A; Sieck U; Cumming W; Akhtar M; Serenius F
    Acta Paediatr Scand; 1984 Nov; 73(6):868-74. PubMed ID: 6395627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How can you differentiate neonatal Bartter's syndrome from hyperprostaglandin (-uria) E2 syndrome?
    Seyberth HW
    Pediatr Nephrol; 1994 Aug; 8(4):407. PubMed ID: 7947025
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal sonographic patterns in Bartter's syndrome.
    Al-Rasheed SA; Patel PJ; Kolawole TM; Al-Mugeiren M; Malabarey T; Al Salloum A; Al-Herbish AS; Al-Jurayyan NA
    Pediatr Radiol; 1996; 26(2):116-9. PubMed ID: 8587809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Complex long-term eating disorder, Bartter's syndrome and pregnancy: a rare combination.
    Morton A
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):275; author reply 275. PubMed ID: 15191461
    [No Abstract]   [Full Text] [Related]  

  • 9. Neonatal Bartter's syndrome with hyperkalemia and normal urinary prostaglandin E2.
    Moudgil A; Bagga A; Germain BM; Klein AH
    Pediatr Nephrol; 1997 Jun; 11(3):387-8. PubMed ID: 9203201
    [No Abstract]   [Full Text] [Related]  

  • 10. Bartter's syndrome presenting during pregnancy: results of amiloride therapy.
    Stokes GS; Andrews BS; Hagon E; Thornell IR; Palmer AA; Posen S
    Med J Aust; 1974 Sep; 2(10):360-5. PubMed ID: 4424542
    [No Abstract]   [Full Text] [Related]  

  • 11. Pre-pubertal growth in the hyperprostaglandin E syndrome.
    Seidel C; Reinalter S; Seyberth HW; Schärer K
    Pediatr Nephrol; 1995 Dec; 9(6):723-8. PubMed ID: 8747113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy complicated with Bartter's syndrome: a case report.
    Nohira T; Nakada T; Akutagawa O; Fujito A; Okabe K; Ioya N; Yoshida M
    J Obstet Gynaecol Res; 2001 Oct; 27(5):267-74. PubMed ID: 11776509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter's syndrome in pregnancy: a case report and review.
    O'Sullivan E; Monga M; Graves W
    Am J Perinatol; 1997 Jan; 14(1):55-7. PubMed ID: 9259898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calciuria in Bartter's and similar syndromes.
    Bianchetti MG; Bettinelli A; Oetliker OH; Sereni F
    Clin Nephrol; 1992 Dec; 38(6):338. PubMed ID: 1468166
    [No Abstract]   [Full Text] [Related]  

  • 15. Endothelium-derived vasoactive substances in Bartter's syndrome.
    Calò L; Cantaro S; Calabrò A; Piarulli F; Rizzolo M; Favaro S; Antonello A; Crepaldi G; Borsatti A
    Angiology; 1995 Oct; 46(10):905-13. PubMed ID: 7486211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter's syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib.
    Haas NA; Nossal R; Schneider CH; Lewin MA; Ocker V; Holder M; Uhlemann F
    Pediatr Crit Care Med; 2003 Apr; 4(2):249-51. PubMed ID: 12749662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Bartter's syndrome: report of a case with early manifestations and persistent hypercalciuria.
    Girardin E; Favre L; Vallotton MB; Paunier L
    Helv Paediatr Acta; 1986 Aug; 41(3):221-8. PubMed ID: 3759484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bartter's syndrome in pregnancy: review of potassium homeostasis in gestation.
    Luqman A; Kazmi A; Wall BM
    Am J Med Sci; 2009 Dec; 338(6):500-4. PubMed ID: 19770791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease.
    Punzi L; Calò L; Schiavon F; Pianon M; Rosada M; Todesco S
    Rev Rhum Engl Ed; 1998 Oct; 65(10):571-4. PubMed ID: 9809361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders.
    Seyberth HW; Königer SJ; Rascher W; Kühl PG; Schweer H
    Pediatr Nephrol; 1987 Jul; 1(3):491-7. PubMed ID: 3153322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.